SCHEMBL20980467

SCHEMBL20980467

c1ccc(-c2ccc(-c3cccc4cn5cccc5cc34)nc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
ALDH1A3 P47895 5/20 0.38
KDM4E B2RXH2 5/20 0.38
ALDH1A2 O94788 4/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
CYP11B1 P15538 3/20 0.35
CYP11B2 P19099 3/20 0.35
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
DHODH Q02127 1/20 0.34
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
GRM4 Q14833 1/20 0.33
HPGD P15428 3/20 0.33
HSD17B10 Q99714 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25712608 0.81 NPC1 (0.39) ALDH1A1ALDH1A3KDM4EALDH1A2NPC1
SCHEMBL20980504 0.78 GRM4 (0.32) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL20980468 0.77 CYP11B1 (0.39) CYP11B1CYP11B2
SCHEMBL26564770 0.72 CYP11B1 (0.44) ALDH1A1KDM4ESMN1; SMN2MAPTCYP11B1
SCHEMBL20980447 0.71
SCHEMBL21981983 0.69 MAPT (0.43) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL10017052 0.68 CYP17A1 (0.40) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL14680917 0.68 HSD17B1 (0.48) NPC1RAB9ASMN1; SMN2CYP11B1CYP11B2
SCHEMBL17680010 0.68 CYP11B1 (0.43) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL12436888 0.68 CYP11B1 (0.43) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11214587-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-01-04 US disclosed
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11214587-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OPRD1 ALDH1A1 2254/4885ALDH1A3 1399/4885KDM4E 3754/4885
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OPRD1 ALDH1A1 2254/4885ALDH1A3 1399/4885KDM4E 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.